EpiBiologics
Laura Brass - Director
Oncology
San Mateo, USA
EpiBiologics is developing bispecific extracellular degraders that selectively localize target degradation to disease tissues.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.